Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.735 USD | +2.05% | -0.18% | +9.00% |
May. 02 | Transcript : Arbutus Biopharma Corporation, Q1 2024 Earnings Call, May 02, 2024 | |
May. 02 | Earnings Flash (ABUS) ARBUTUS BIOPHARMA CORPORATION Posts Q1 Revenue $1.5M | MT |
Evolution of the average Target Price on Arbutus Biopharma Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Arbutus Biopharma Corporation
HC Wainwright | |
JMP Securities | |
Chardan Research | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- ABUS Stock
- Consensus Arbutus Biopharma Corporation